J&J Submits Doripenem NDA For Hospital Acquired Pneumonia
This article was originally published in The Pink Sheet Daily
Executive Summary
Complicated abdominal and urinary tract infections NDA for the novel antibiotic was submitted in December.
You may also be interested in...
FDA Stalls J&J’s Doribax For Hospital-Acquired Pneumonia
Agency needs three more months, company says.
FDA Stalls J&J’s Doribax For Hospital-Acquired Pneumonia
Agency needs three more months, company says.
Ortho-McNeil Gets FDA Approval For Complicated Intra-Abdominal/UTI Therapy Doribax
Studies of the novel injectable carbapenem antibiotic showed activity in several forms of Gram-positive and Gram-negative bacteria, including Pseudomonas.